178 related articles for article (PubMed ID: 30221906)
1. Evaluation of physiologic and abnormal glucose uptake in palatine tonsils: differential diagnostics with sequential dual-time-point 2-deoxy-2-[18F]FDG PET/CT.
Pietrzak AK; Kazmierska J; Marszalek A; Cholewinski W
Q J Nucl Med Mol Imaging; 2020 Sep; 64(3):299-306. PubMed ID: 30221906
[TBL] [Abstract][Full Text] [Related]
2. Sequential
Pietrzak A; Kazmierska J; Cholewinski W
Hell J Nucl Med; 2017; 20 Suppl():80-92. PubMed ID: 29324917
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of normal FDG uptake in palatine tonsil and its potential value for detecting occult head and neck cancers: a PET CT study.
Wong WL; Gibson D; Sanghera B; Goodchild K; Saunders M
Nucl Med Commun; 2007 Sep; 28(9):675-80. PubMed ID: 17667745
[TBL] [Abstract][Full Text] [Related]
4. Palatine tonsil SUVmax on FDG PET-CT as a discriminator between benign and malignant tonsils in patients with and without head and neck squamous cell carcinoma of unknown primary.
Pencharz D; Dunn J; Connor S; Siddiqui A; Sriskandan N; Thavaraj S; Jeannon JP; Oakley R; Lei M; Guerrero-Urbano T; Cook GJ; Szyszko TA
Clin Radiol; 2019 Feb; 74(2):165.e17-165.e23. PubMed ID: 30454841
[TBL] [Abstract][Full Text] [Related]
5. Determinants of physiological uptake of 18F-fluorodeoxyglucose in palatine tonsils.
Birkin E; Moore KS; Huang C; Christopher M; Rees JI; Jayaprakasam V; Fielding PA
Medicine (Baltimore); 2018 Jun; 97(24):e11040. PubMed ID: 29901601
[TBL] [Abstract][Full Text] [Related]
6. Sequential delayed [18 F]FDG PET/CT examinations in the pharynx.
Pietrzak AK; Marszalek A; Kazmierska J; Kunikowska J; Golusinski P; Suchorska WM; Michalak M; Cholewinski W
Sci Rep; 2020 Feb; 10(1):2910. PubMed ID: 32076053
[TBL] [Abstract][Full Text] [Related]
7. Squamous cell carcinoma of the palatine tonsils: FDG standardized uptake value ratio as a biomarker to differentiate tonsillar carcinoma from physiologic uptake.
Davison JM; Ozonoff A; Imsande HM; Grillone GA; Subramaniam RM
Radiology; 2010 May; 255(2):578-85. PubMed ID: 20413767
[TBL] [Abstract][Full Text] [Related]
8. CT texture analysis of tonsil cancer: Discrimination from normal palatine tonsils.
Kim TY; Lee JY; Lee YJ; Park DW; Tae K; Choi YY
PLoS One; 2021; 16(8):e0255835. PubMed ID: 34379652
[TBL] [Abstract][Full Text] [Related]
9. Dual-time-point PET/CT study protocol can improve the larynx cancer diagnosis.
Pietrzak AK; Kazmierska J; Marszalek A; Golusinski P; Heydrych A; Wiechec K; Cholewinski W
Rep Pract Oncol Radiother; 2020; 25(4):533-538. PubMed ID: 32477019
[TBL] [Abstract][Full Text] [Related]
10. Normal FDG uptake in the adenoids and palatine tonsils in children on PET/MRI.
Kumbhar SS; Qi J
Pediatr Radiol; 2020 Jun; 50(7):958-965. PubMed ID: 32198664
[TBL] [Abstract][Full Text] [Related]
11. The clinical value of texture analysis of dual-time-point
Nakajo M; Jinguji M; Aoki M; Tani A; Sato M; Yoshiura T
Eur Radiol; 2020 Mar; 30(3):1759-1769. PubMed ID: 31728684
[TBL] [Abstract][Full Text] [Related]
12. The role of fluorodeoxyglucose-positron emission tomography/computed tomography in differentiating between benign and malignant adrenal lesions.
Ozcan Kara P; Kara T; Kara Gedik G; Kara F; Sahin O; Ceylan Gunay E; Sari O
Nucl Med Commun; 2011 Feb; 32(2):106-12. PubMed ID: 21085046
[TBL] [Abstract][Full Text] [Related]
13. Increased
Okuyama C; Matsushima S; Nishimura M; Yamada K
Ann Nucl Med; 2019 May; 33(5):368-373. PubMed ID: 30689118
[TBL] [Abstract][Full Text] [Related]
14. PET/CT findings within the contralateral tonsil following unilateral tonsillectomy.
Hirshoren N; Olayos E; Callahan J; Lau E
Laryngoscope; 2016 Nov; 126(11):2480-2483. PubMed ID: 27114188
[TBL] [Abstract][Full Text] [Related]
15. Incidental FDG-Avid Focuses in Palatine Tonsils on PET/CT.
Reinholdt KB; Dias AH; Hoff CM; Gormsen LC; Klug TE
Laryngoscope; 2022 Dec; 132(12):2370-2378. PubMed ID: 35226376
[TBL] [Abstract][Full Text] [Related]
16. Initial and Delayed Metabolic Activity of Palatine Tonsils Measured with the PET/CT-Dedicated Parameters.
Pietrzak A; Marszalek A; Paterska M; Golusinski P; Narozna J; Cholewinski W
Diagnostics (Basel); 2020 Oct; 10(10):. PubMed ID: 33080852
[TBL] [Abstract][Full Text] [Related]
17. Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results.
Christlieb SB; Strandholdt CN; Olsen BB; Mylam KJ; Larsen TS; Nielsen AL; Rohde M; Gerke O; Olsen KE; Møller MB; Kristensen BW; Abildgaard N; Alavi A; Høilund-Carlsen PF
Eur J Nucl Med Mol Imaging; 2016 Sep; 43(10):1824-36. PubMed ID: 27102266
[TBL] [Abstract][Full Text] [Related]
18. [Value of dual-time-point (18)F-fluorodeoxyglucose integrated positron emission and computed tomography in differentiation of malignant from benign gastrointestinal diseases].
Xu XX; Cheng J; Xu WG; Dai D; Song XY; Ma WC; Zhu L; Zhu X
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):364-8. PubMed ID: 22883458
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of dual-time-point 18F-FDG PET imaging in resectable non-small cell lung cancer.
Shimizu K; Okita R; Saisho S; Yukawa T; Maeda A; Nojima Y; Nakata M
Ann Nucl Med; 2015 Dec; 29(10):854-60. PubMed ID: 26254228
[TBL] [Abstract][Full Text] [Related]
20. [Differentiation of malignant and benign superficial lymph nodes by dual time point 18F-FDG PET].
Su MG; Fan QP; Tian Y; Li FL; Yang XC; Li L; Fan CZ; Tian R
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May; 40(3):517-20. PubMed ID: 19627018
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
